← Back to Patent Explorer
US5550040A Expired / Lapsed US ⏱️ 0.0 years remaining

Method, reagents and kits for the detection of Neisseria gonorrhoeae

Assignee: Roche Molecular Systems Inc
•
Filing: 1994-03-17
•
Granted: 1996-08-27
•
Expires: 2014-03-17
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Methods, reagents and kits are provided for simultaneously amplifying and detecting polynucleotide sequences in bacteria causing Neisseria gonorrhoeae and/or Chlamydia trachomatis using primers and probes specific for each bacterial species.

Inventors

  • 👤 Ashok P. Purohit
  • 👤 Sheryl B. Silver

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-31 05:09
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/68; C12Q1/6876; C12Q1/6888; C12Q1/689; Y; Y10; Y10S; Y10S435/00; Y10S435/81

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 257 words
A method for determining the presence or absence of N. gonorrhoeae and/or C. trachomatis in a fluid sample suspected of containing either or both N. gonorrhoeae and C. trachomatis comprising: (a) treating said sample with an aqueous solution containing at least four oligonucleotide primers, two of said primers being capable of hybridizing selectively with the two complementary strands of N. gonorrhoeae DNA which contain the target sequence, said primers having SEQ ID NO: 1 and SEQ ID NO:2, respectively, and the other two primers being capable of hybridizing selectively with the two complementary strands of C. trachomatis DNA which contain the target sequence, said primers having SEQ ID NO:4 and SEQ ID NO:5, respectively, said aqueous solution also containing an inert organic polar solvent as a cosolvent; (b) synthesizing an extension product of each of said primers, which extension product(s) containing the target DNA sequence(s), and amplifying said target sequences(s) if present; (c) treating said sample, after the intended amplification(s), with two oligonucleotide probes: one probe having sequence SEQ ID NO:3 which is uniquely complementary to a sequence in the amplified region of N. gonorrhoeae, and a second probe having sequence SEQ ID NO:6 which is uniquely complementary to a sequence in the amplified region of C. trachomatis; (d) incubating the amplified target region(s), if any, with each of the oligonucleotide probes, under stringent conditions, and allowing for hybridization between each of said probes and the target region for said probe; and (e) detecting hybrids formed between the amplified target regions(s), if any, and the oligonucleotide probe(s).
Claim 2
Independent Claim 257 words
A method for determining the presence or absence of N. gonorrhoeae and/or C. trachomatis in a fluid sample suspected of containing either or both N. gonorrhoeae and C. trachomatis comprising: (a) treating said sample with an aqueous solution containing at least four oligonucleotide primers, two of said primers being capable of hybridizing selectively with the two complementary strands of N. gonorrhoeae DNA which contain the target sequence, said primers having SEQ ID NO: 1 and SEQ ID NO:2, respectively, and the other two primers being capable of hybridizing selectively with the two complementary strands of C. trachomatis DNA which contain the target sequence, said primers having SEQ ID NO:4 and SEQ ID NO:5, respectively, said aqueous solution also containing an inert organic polar solvent as a cosolvent; (b) synthesizing an extension product of each of said primers, which extension product(s) containing the target DNA sequence(s), and amplifying said target sequences(s) if present; (c) treating said sample, after the intended amplification(s), with two oligonucleotide probes: one probe having sequence SEQ ID NO:3 which is uniquely complementary to a sequence in the amplified region of N. gonorrhoeae, and a second probe having sequence SEQ ID NO:6 which is uniquely complementary to a sequence in the amplified region of C. trachomatis; (d) incubating the amplified target region(s), if any, with each of the oligonucleotide probes, under stringent conditions, and allowing for hybridization between each of said probes and the target region for said probe; and (e) detecting hybrids formed between the amplified target regions(s), if any, and the oligonucleotide probe(s).
Claim 3
Dependent Claim 17 words
The method of claim 1, wherein Step (d) is carried out in the presence of a buffer.
Claim 4
Dependent Claim 16 words
The method of claim 2 wherein the buffer comprises NaSCN at a concentration of about 4.0M.
Claim 5
Dependent Claim 81 words
A PCR kit for the detection of either or both N. gonorrhoeae and C. trachomatis, comprising a container having an aqueous solution which includes oligonucleotide primers having sequences SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:4 and SEQ ID NO:5, said aqueous solution further containing as a cosolvent an organic polar solvent; and separate from said container, an oligonucleotide probe for N. gonorrhoeae having sequence SEQ ID NO:3 and a probe for C. trachomatis having the sequence SEQ ID NO:6.
Claim 6
Dependent Claim 81 words
A PCR kit for the detection of either or both N. gonorrhoeae and C. trachomatis, comprising a container having an aqueous solution which includes oligonucleotide primers having sequences SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:4 and SEQ ID NO:5, said aqueous solution further containing as a cosolvent an organic polar solvent; and separate from said container, an oligonucleotide probe for N. gonorrhoeae having sequence SEQ ID NO:3 and a probe for C. trachomatis having the sequence SEQ ID NO:6.
Claim 7
Dependent Claim 14 words
The kit of claim 4 wherein the probes are immobilized on a microtiter plate.
Claim 8
Dependent Claim 11 words
The kit of claim 5 wherein the oligonucleotide primers are labeled.
Claim 9
Dependent Claim 12 words
The kit of claim 6 wherein the primers are labeled with biotin.
Claim 10
Dependent Claim 25 words
The kit of claim 4 wherein said cosolvent is present in an amount of from about 1% to about 20% by volume of said solution.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1999-08-27 2000-02-26 2000-08-27 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2003-08-27 2004-02-26 2004-08-27 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2007-08-27 2008-02-26 2008-08-27 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag